Lincoln Pharmaceuticals Ltd — Azithromycin Exporter Profile
Indian Pharmaceutical Exporter · #1 for Azithromycin · $4.8M export value · DGFT Verified
Lincoln Pharmaceuticals Ltd is the #1 Indian exporter of Azithromycin with $4.8M in export value and 97 verified shipments. Lincoln Pharmaceuticals Ltd holds a 2.6% market share in Azithromycin exports across 16 countries.
Lincoln Pharmaceuticals Ltd — Azithromycin Export Profile: Buyers & Destinations
Where Does Lincoln Pharmaceuticals Ltd Export Azithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $662.4K | 23 | 27.6% |
| NIGERIA | $473.7K | 17 | 19.7% |
| SUDAN | $469.6K | 30 | 19.6% |
| MYANMAR | $218.8K | 12 | 9.1% |
| FRANCE | $175.1K | 4 | 7.3% |
| IRAQ | $110.2K | 7 | 4.6% |
| THAILAND | $105.8K | 4 | 4.4% |
| MADAGASCAR | $50.8K | 6 | 2.1% |
| UGANDA | $27.2K | 12 | 1.1% |
| SRI LANKA | $22.6K | 1 | 0.9% |
Lincoln Pharmaceuticals Ltd exports Azithromycin to 21 countries. The largest destination is TANZANIA accounting for 27.6% of Lincoln Pharmaceuticals Ltd's Azithromycin shipments, followed by NIGERIA (19.7%) and SUDAN (19.6%). These destinations reflect Lincoln Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Azithromycin from Lincoln Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HEKO PHARMACY LTD | TANZANIA | $580.5K | 18 |
| GENERICS AND SPECIALITIES LTD | NIGERIA | $473.7K | 17 |
| AMIPHARMA LABORATORIES LTD | SUDAN | $191.9K | 13 |
| PLANET PHARMA | FRANCE | $175.1K | 4 |
| AMIPHARMA LABORATORIES LIMITED | SUDAN | $133.9K | 12 |
| KOKNAR TAS ITH IHR SAN VE TIC LTD S | IRAQ | $110.2K | 7 |
| A.P.L. | SUDAN | $76.9K | 2 |
| JDS CO., LTD | MYANMAR | $72.0K | 4 |
| APL | SUDAN | $66.8K | 3 |
| WIN HTUN GARMENT TRADING LIMITED | THAILAND | $54.9K | 2 |
Lincoln Pharmaceuticals Ltd supplies Azithromycin to 34 buyers globally. The largest buyer is HEKO PHARMACY LTD (TANZANIA), followed by GENERICS AND SPECIALITIES LTD (NIGERIA) and AMIPHARMA LABORATORIES LTD (SUDAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Azithromycin Export Value and How Much Does Lincoln Pharmaceuticals Ltd Contribute?
India exported $74.0M worth of Azithromycin through 15,000 shipments from 853 suppliers to 169 countries, serving 2,397 buyers globally. Lincoln Pharmaceuticals Ltd contributes $4.8M to this total, accounting for 2.6% of India's Azithromycin exports. Lincoln Pharmaceuticals Ltd ships Azithromycin to 21 countries through 34 buyers.
What Is the Average Shipment Value for Lincoln Pharmaceuticals Ltd's Azithromycin Exports?
Lincoln Pharmaceuticals Ltd's average Azithromycin shipment value is $50.0K per consignment, based on 97 shipments totaling $4.8M. The largest destination is TANZANIA (27.6% of Lincoln Pharmaceuticals Ltd's Azithromycin exports).
How Does Lincoln Pharmaceuticals Ltd Compare to Other Indian Azithromycin Exporters?
Lincoln Pharmaceuticals Ltd ranks #1 among 853 Indian Azithromycin exporters with a 2.6% market share. The top 3 exporters are LUPIN LIMITED ($11.0M), ALEMBIC PHARMACEUTICALS LIMITED ($8.7M), CIPLA LIMITED ($8.4M). Lincoln Pharmaceuticals Ltd processed 97 shipments to 16 destination countries.
What Azithromycin Formulations Does Lincoln Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Azithromycin Oral Suspension 200 mg/5 ml | $293.6K | 14 |
| Azithromycin oral Suspension 200 mg/ 5 | $170.0K | 5 |
| Azithromycin Tablets USP (Zithrolin-250) | $140.0K | 5 |
| Azithromycin Tablets USP (Zithrolin-500) | $130.3K | 5 |
| Combipack of Azithromycin For Oral Suspe | $114.0K | 8 |
| Azithromycin Tablets USP 500 mg (Azilin | $95.4K | 2 |
| AZITHROMYCIN CAPSULES 500 MG (AZIMAX-500)(271389X1X3 CAP) | $77.1K | 3 |
| Azithromycin Oral Suspension 200 mg/ 5 | $67.6K | 2 |
| Azithromycin oral Suspension 200 mg/ 5 m | $67.4K | 2 |
| Azithromycin Tablets USP 500 mg (AZITHRO | $54.7K | 2 |
Lincoln Pharmaceuticals Ltd exports 83 distinct Azithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Azithromycin Oral Suspension 200 mg/5 ml with 14 shipments worth $293.6K.
Regulatory Requirements: Exporting Azithromycin to Key Markets
What Lincoln Pharmaceuticals Ltd must comply with to export Azithromycin to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Lincoln Pharmaceuticals Ltd Compare to Nearest Azithromycin Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | AJANTA PHARMA LIMITED | $5.8M | 278 | 20 | $21.0K |
| 3 | MICRO LABS LIMITED | $5.5M | 110 | 17 | $50.0K |
| 1 | LINCOLN PHARMACEUTICALS LTD ★ | $4.8M | 97 | 16 | $50.0K |
| 10 | MACLEODS PHARMACEUTICALS LTD | $4.5M | 91 | 14 | $50.0K |
| 13 | CAPLIN POINT LABORATORIES LIMITED | $2.9M | 57 | 10 | $50.0K |
Lincoln Pharmaceuticals Ltd ranks #1 among 853 Indian Azithromycin exporters. Average shipment value of $50.0K compared to the market average of $86.8K. The closest competitors by value are AJANTA PHARMA LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Azithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,394 | 16.0% |
| SAHAR AIR | 2,211 | 14.7% |
| DELHI AIR CARGO ACC (INDEL4) | 1,693 | 11.3% |
| DELHI AIR | 1,106 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 902 | 6.0% |
| NHAVA SHEVA SEA (INNSA1) | 870 | 5.8% |
| Bombay Air | 618 | 4.1% |
| JNPT | 408 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Azithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Azithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lincoln Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 139 individual customs records matching Lincoln Pharmaceuticals Ltd exporting Azithromycin, covering 83 formulations to 21 countries via 34 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 169+ countries, 2,397+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Azithromycin Export Data from Lincoln Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lincoln Pharmaceuticals Ltd's Azithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lincoln Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Azithromycin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lincoln Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Azithromycin. For current shipment-level data, contact TransData Nexus.